Dr. Agrawals Eye Hospital

4,088.20
-164.40
(-3.87%)
ann
There are new updates from the company8 hours ago
Viewcross
right
Market Cap
1,921.43 Cr
EPS
98.64
PE Ratio
38.85
Dividend Yield
0.06 %
52 Week High
7,300.00
52 Week Low
2,800.00
PB Ratio
10.86
Debt to Equity
1.85
Sector
Hospitals
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from1 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy+100.00 %
+100.00 %
Hold0.0 %
0.0 %
Sell0.0 %
0.0 %
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,129.40
#1 1,09,792.59
102.90
5,584.10
18.77
#1 1,058
-17.46
59.65
6,492.05
93,345.72
71.54
#1 19,165.50
14.74
917
49.14
54.11
671.80
50,718.09
61.76
6,931.20
8.99
645
#1 89.49
62.72
1,673.40
34,197.74
42.51
5,093.40
10.96
790
2.66
65.20
1,213.85
32,602.48
64.67
2,759.20
#1 25.09
326
15.71
53.06
622.50
24,908.65
70.52
2,511.20
12.94
336
20.76
61.44
453.35
22,645.42
83.71
3,723.70
22.85
205
-69.22
62.46
1,378.50
13,998.90
56.82
1,334.00
10.76
218
10.06
59.81
5,180.00
11,456.25
#1 27.61
599.90
11.69
58
8.85
42.49
1,536.85
10,076.51
57.85
1,095.50
21.32
177
20.14
46.80
Growth Rate
Revenue Growth
20.24 %
Net Income Growth
25.75 %
Cash Flow Change
28.94 %
ROE
-9.43 %
ROCE
-0.42 %
EBITDA Margin (Avg.)
4.44 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
118
137
150
156
172
179
141
203
270
324
386
Expenses
104
120
127
130
141
130
109
144
193
228
267
EBITDA
15
17
23
26
31
49
31
59
77
96
119
Operating Profit %
12 %
12 %
14 %
15 %
17 %
26 %
22 %
29 %
28 %
29 %
30 %
Depreciation
6
9
9
10
11
21
19
20
20
27
37
Interest
3
4
3
3
3
8
6
6
7
7
13
Profit Before Tax
5
-1
11
13
17
20
6
32
49
62
69
Tax
-0
-1
4
7
6
6
7
8
13
16
18
Net Profit
6
0
7
7
12
14
-1
24
37
46
51
EPS in ₹
12.12
0.08
15.61
14.42
25.35
29.11
-3.06
51.28
78.55
98.64
109.50

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
69
79
72
81
100
141
155
314
390
496
Fixed Assets
27
34
33
36
55
94
96
214
260
316
Current Assets
23
24
20
23
30
30
44
50
47
60
Capital Work in Progress
0
1
1
3
0
0
0
27
62
97
Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
43
44
38
42
45
47
60
73
67
83
Total Liabilities
69
79
72
81
100
141
155
314
390
496
Current Liabilities
31
36
27
37
35
39
49
53
55
81
Non Current Liabilities
15
19
16
9
19
45
52
183
222
258
Total Equity
24
23
29
35
46
56
55
78
113
157
Reserve & Surplus
19
19
25
30
41
51
50
74
109
152
Share Capital
5
5
5
5
5
5
5
5
5
5

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-1
0
0
-1
2
2
15
7
-1
6
Investing Activities
-10
-17
-8
-11
-25
-17
-11
-46
-71
-70
Operating Activities
14
17
20
19
25
39
34
57
70
90
Financing Activities
-5
-0
-12
-8
2
-20
-8
-4
0
-14

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
74.02 %
73.77 %
73.60 %
72.38 %
72.15 %
72.00 %
71.91 %
71.90 %
71.90 %
71.90 %
71.90 %
71.90 %
71.90 %
71.90 %
71.90 %
71.90 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.28 %
0.00 %
0.64 %
0.65 %
0.83 %
0.84 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.96 %
1.03 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
21.77 %
22.07 %
22.23 %
23.32 %
23.55 %
23.63 %
23.24 %
22.80 %
22.65 %
22.66 %
22.15 %
21.84 %
21.74 %
21.77 %
20.51 %
20.44 %
Others
4.21 %
4.16 %
4.17 %
4.30 %
4.30 %
4.37 %
4.86 %
5.31 %
5.46 %
5.45 %
5.67 %
6.27 %
5.72 %
5.69 %
5.80 %
5.79 %
No of Share Holders
2,492
2,462
2,444
2,741
2,764
2,791
2,858
3,006
3,110
3,169
3,471
3,423
3,572
3,808
4,510
15,115

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 1.5 1.2 1.5 0.00 0.00 3 3 2.5 0.00
Dividend Yield (%) 0.00 0.25 0.33 0.79 0.00 0.00 0.33 0.1 0.06 0.00

Corporate Action

Announcements

Closure of Trading Window8 hours ago
Commencement Of Operation Of A New Branch8 days ago
Announcement Under Regulation 30(5) Of SEBI (LODR) Regulations 2015- Commencement Of Operation Of A New BranchMar 03, 2025
Announcement under Regulation 30 (LODR)-Credit RatingFeb 17, 2025
Integrated Filing (Financial)Feb 14, 2025
Announcement Under Regulation 30(5) Of SEBI (LODR) Regulations 2015Feb 14, 2025
Results- Financial Results For The Quarter And Nine Months Ended 31-12-2024Feb 14, 2025
Board Meeting Outcome for Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024Feb 14, 2025
Board Meeting Intimation for Considering And Approving The Unaudited Financial Results For The Quarter And Nine-Months Ended December 31 2024Feb 07, 2025
Clarification On Price MovementJan 30, 2025
Clarification sought from Dr Agarwals Eye Hospital LtdJan 29, 2025
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Jan 24, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 07, 2025
Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015- Commencement Of Operation Of A New BranchDec 27, 2024
Closure of Trading WindowDec 27, 2024
Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015- Commencement Of Operation Of A New BranchDec 13, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 05, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 05, 2024
Shareholder Meeting / Postal Ballot-Scrutinizers ReportDec 02, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 29, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 19, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 15, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 12, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 07, 2024
Copy Of Newspaper PublicationNov 02, 2024
Shareholder Meeting / Postal Ballot-Notice of Postal BallotNov 01, 2024
Announcement under Regulation 30 (LODR)-Change in ManagementOct 29, 2024
Corporate Action-Board approves DividendOct 29, 2024
Results- Financial Results For The Quarter And 6 Months Ended 30.09.2024Oct 29, 2024
Board Meeting Outcome for Outcome Of Board MeetingOct 29, 2024
Update on board meetingOct 24, 2024
Board Meeting Intimation for For Considering The Un-Audited Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2024Oct 23, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 22, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 21, 2024
Disclosure Under Regulation 30 (LODR)- Commencement Of Operation Of A New BranchOct 21, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 08, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 04, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateSep 30, 2024
Closure of Trading WindowSep 30, 2024
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.Sep 28, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateSep 25, 2024
Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.Sep 23, 2024
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.Sep 23, 2024
Disclosure Under Regulation 30 (LODR)- Commencement Of Operation Of A New BranchSep 23, 2024
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Sep 22, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateSep 19, 2024
Announcement under Regulation 30 (LODR)-CessationSep 17, 2024
Updates on Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.Sep 16, 2024
Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.Sep 16, 2024
Updates on Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.Sep 16, 2024

Technical Indicators

RSI(14)
Neutral
40.30
ATR(14)
Less Volatile
264.92
STOCH(9,6)
Neutral
43.67
STOCH RSI(14)
Neutral
25.47
MACD(12,26)
Bullish
23.32
ADX(14)
Weak Trend
17.05
UO(9)
Bearish
41.02
ROC(12)
Downtrend And Accelerating
-2.58
WillR(14)
Oversold
-87.51